| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10172106 | Respiratory Investigation | 2014 | 6 Pages |
Abstract
Cisplatin plus pemetrexed may be superior and should continue to be the standard front-line chemotherapeutic regimen for inoperable MPM.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Takehito Shukuya, Toshiaki Takahashi, Hisao Imai, Takaaki Tokito, Akira Ono, Hiroaki Akamatsu, Tetsuhiko Taira, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo, Nobuyuki Yamamoto,